Skip to content
  • Latest News
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Terms and Conditions
  • About Us
Archyde

Archyde

  • News
  • World
  • Economy
  • Technology
  • Health
  • Entertainment
  • Sport

Ziltivekimab

ISHCEMIA-CKD EXTEND: Invasive Eingriffe bringen bei CKD keine Überlebensvorteile

ISCHEMIA-CKD EXTEND: Invasive Strategy Does Not Improve Survival in CKD

November 16, 2026 by Priya Deshmukh - Senior Editor, Health

Long-term data from the ISCHEMIA-CKD EXTEND trial show that an invasive strategy does not improve survival compared with conservative treatment in stable coronary artery disease and advanced chronic kidney disease, … Read More

Categories Health Tags AI, Artificial intelligence, biomarker, KI, Künstliche Intelligenz, Ziltivekimab

Recent Posts

  • West End Star Casting Reliance Risks Stunting Audience Intellect
  • INEOS Adds Young Talent to Squad to Challenge Pogačar in 2027
  • Eisenkot Says Netanyahu Cannot Remain PM Amid Alleged Vote Meddling
  • ASX 200 Drops as Elders Reports FY26 Results, New Hope Launches Hybrid Offer
  • Ancient Virus Linked to Human Brain Development Differences
  • Latest News
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Terms and Conditions
  • About Us
© 2026 Archyde — All Rights Reserved. Contact | Privacy Policy